Literature DB >> 18950882

Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy - A follow-up study.

Christian M Zechmann1, Khurram Aftab, Bernd Didinger, Frederik L Giesel, Patrik Zamecnik, Christian Thieke, Jurgen J Fütterer, Annette Kopp-Schneider, Hans-Ulrich Kauczor, Stefan Delorme.   

Abstract

BACKGROUND AND
PURPOSE: The shrinking effect of androgen deprivation therapy (ADT) on prostate volume is a known finding, but data on volume changes during radiotherapy are inconsistent. We examined patients with and without ADT undergoing intensity modulated radiotherapy (IMRT) and performed follow-up examinations to study volume changes before and after radiotherapy. METHODS AND MATERIALS: Prostate volumes between planning magnetic resonance imaging (MRI) and last available follow-up MRI were retrospectively determined in 39 patients. Median time interval between first and last MRI was 233days (range 126-813). Two observers performed volume measurements in consensus and were blind to the timing of MRI. Volume changes over MRI were determined using the ellipsoid formula. Data of patients with and without ADT were compared by a linear mixed model.
RESULTS: Of 39 patients, 22 had ADT with a median duration of 5months (range 1-24). ADT patients showed lower prostate volume throughout the study period (-28% to 38%). Although individual shrinking effect was highly variable, patients treated with IMRT but without ADT showed a significantly larger volume reduction (26.1%) than patients with ADT (12.9%, p<0.05).
CONCLUSIONS: Patients undergoing IMRT show definite prostate shrinkage. The rate is slowed down after 6months in both groups, whereas the volume reduction is significantly larger in patients without ADT. Nevertheless there is no adding effect of ADT+IMRT vs. IMRT alone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950882     DOI: 10.1016/j.radonc.2008.09.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.

Authors:  Andreas M Hötker; Yousef Mazaheri; Junting Zheng; Chaya S Moskowitz; Joshua Berkowitz; Joshua E Lantos; Xin Pei; Michael J Zelefsky; Hedvig Hricak; Oguz Akin
Journal:  Eur Radiol       Date:  2015-03-29       Impact factor: 5.315

2.  Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.

Authors:  Yi Wang; Jason A Efstathiou; Gregory C Sharp; Hsiao-Ming Lu; I Frank Ciernik; Alexei V Trofimov
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

3.  Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.

Authors:  Alexei Trofimov; Paul L Nguyen; Jason A Efstathiou; Yi Wang; Hsiao-Ming Lu; Martijn Engelsman; Scott Merrick; Chee-Wai Cheng; James R Wong; Anthony L Zietman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

4.  Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer.

Authors:  Connor Chevli; Ramkishen Narayanan; Lisa Rambarran; Gregory Kubicek; K Kent Chevli; Michael Duff
Journal:  Res Rep Urol       Date:  2013-01-14

5.  Relationship between prostate volume changes and treatment duration of neoadjuvant androgen deprivation during intensity-modulated radiation therapy for Japanese patients with prostate cancer.

Authors:  Masashi Tomida; Kuniyasu Okudaira; Takeshi Kamomae; Hiroshi Oguchi; Yoshikazu Miyake; Kazuo Yoneda; Yoshiyuki Itoh
Journal:  Nagoya J Med Sci       Date:  2016-08       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.